• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Guardian Pharmacy Services Opens New Columbus, Ohio, Location, Strengthening Long-Term Care Presence in Ohio, Kentucky and West Virginia

    4/14/25 10:03:00 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $GRDN alert in real time by email

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, and Mullaney's Pharmacy, a Guardian Pharmacy member based in Cincinnati, today announced the opening of a new pharmacy in Columbus, Ohio. Operating as Guardian Pharmacy of Ohio, the new location – together with the Cincinnati pharmacy – will strengthen Guardian's presence in the region and allow it to provide even better service to residents in assisted living, skilled nursing and behavioral health communities as well as individuals with intellectual and developmental disabilities across Ohio, northern and central Kentucky, and western West Virginia.

    Since joining Guardian in 2020, Mullaney's Pharmacy has experienced substantial business growth, tripling the number of residents served in less than five years. The addition of Guardian Pharmacy of Ohio will enhance Mullaney's capabilities, enabling faster delivery times and greater access to hands-on medication management to meet the growing demand from LTC communities and residents.

    "As a third-generation pharmacist leading the business my grandfather founded, I've seen firsthand how LTC pharmacies can make a difference in the lives of the residents and communities we serve," said Tom Mullaney, RPh, president of Mullaney's Pharmacy and Guardian Pharmacy of Ohio. "The support of our customers has fueled our growth and made it possible to open the Columbus pharmacy. This marks a significant milestone for us and enhances our ability to serve LTC communities more efficiently while delivering the same high-quality care, expertise and service they know and trust."

    The 5,600-square-foot Columbus facility will house state-of-the-art technology and automation, as well as a training center to provide in-service and clinical instruction courses for community staff and pharmacy employees. Mullaney, together with Director of Operations Troy Stinson, will oversee operations at Guardian Pharmacy of Ohio alongside Joshua Heiden, pharmacist-in-charge.

    As part of the Guardian Pharmacy Services family, the Ohio pharmacies benefit from the company's local management business model, which enables the local pharmacy teams to focus on customer service and the specialized needs of the communities and residents they serve, while Guardian's centralized Corporate Support Team assists with the many complex behind-the-scenes business functions, including data analytics, HR, IT, payor relations, national sales and more.

    "With its strategic location in Columbus, Guardian Pharmacy of Ohio allows Tom and his team to provide even more responsive, local support to the LTC communities and their residents," said Fred Burke, president and CEO of Guardian Pharmacy Services. "This new pharmacy is a testament to their leadership and commitment to exceptional care, and we're proud to support their continued success and growth in the region."

    Founded in 2004, Guardian Pharmacy Services has expanded from a single location to 51 pharmacies serving 38 states. This growth has been fueled by a balanced strategy of organic expansion, greenfield startups, and acquisitions, positioning the company for continued success in a rapidly evolving market. For more information, visit www.guardianpharmacy.com.

    About Guardian Pharmacy Services

    Guardian Pharmacy Services is a leading long-term care pharmacy services company that provides an extensive suite of technology-enabled services designed to ensure residents of long-term health care facilities ("LTCFs") are on the appropriate drug regimen and to promote medication adherence, which in turn helps reduce the cost of care and improve clinical outcomes. As of December 31, 2024, our 51 pharmacies served approximately 186,000 residents in approximately 7,000 LTCFs across 38 states.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250414801443/en/

    Andrew Agan

    Cookerly PR

    404-816-2037

    [email protected]

    Get the next $GRDN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GRDN

    DatePrice TargetRatingAnalyst
    3/30/2026$44.00Buy
    Jefferies
    10/10/2025$30.00Outperform
    Oppenheimer
    10/21/2024$21.00Outperform
    Raymond James
    10/21/2024$22.00Buy
    Truist
    More analyst ratings

    $GRDN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Guardian Pharmacy Services Announces Pricing of Upsized Underwritten Public Offering of Class A Common Stock

    Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the pricing of its upsized underwritten public offering (the "Offering") of 6,000,000 shares of its Class A common stock at a public offering price of $31.00 per share, of which 4,980,000 shares will be sold by certain selling stockholders and 1,020,000 shares will be issued and sold by Guardian as part of a non-dilutive "synthetic secondary" transaction, as described below. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of Class A common stock at the public offering price, less the underwriting discount. The Offering is expected to cl

    3/19/26 6:10:00 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock

    Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the launch of a proposed underwritten public offering (the "Offering") of 5,000,000 shares of its Class A common stock, consisting of 3,980,000 shares being offered by certain selling stockholders and 1,020,000 newly issued shares being offered by Guardian as part of a non-dilutive "synthetic secondary" transaction, as described below. In addition, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 750,000 shares of Class A common stock at the public offering price, less the underwriting discount. The proposed Offering is considered non-dilutive as Guardian inte

    3/18/26 4:20:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the fourth quarter and full year ended December 31, 2025. The Company also raised its full-year 2026 Adjusted EBITDA guidance. Fourth Quarter Financial Results Revenue of $397.6 million, up 17% year-over-year with organic growth of 12%. Residents served ended the quarter at approximately 205,000, up 10% year-over-year. Net Income of $21.3 million, up 81% from $11.8 million in the prior-year period. Adjusted EBITDA of $39.5 million, up 53% year over year. Diluted EPS of $0.33 for the quarter, with Adjusted

    3/11/26 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    SEC Filings

    View All

    SEC Form DEFA14A filed by Guardian Pharmacy Services Inc.

    DEFA14A - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

    3/26/26 7:20:13 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form DEF 14A filed by Guardian Pharmacy Services Inc.

    DEF 14A - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

    3/26/26 7:18:01 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SCHEDULE 13D/A filed by Guardian Pharmacy Services Inc.

    SCHEDULE 13D/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    3/24/26 6:17:38 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $GRDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $GRDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Jefferies initiated coverage on Guardian Pharmacy Services with a new price target

    Jefferies initiated coverage of Guardian Pharmacy Services with a rating of Buy and set a new price target of $44.00

    3/30/26 8:19:01 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Oppenheimer initiated coverage on Guardian Pharmacy Services with a new price target

    Oppenheimer initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $30.00

    10/10/25 8:37:40 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Raymond James initiated coverage on Guardian Pharmacy Services with a new price target

    Raymond James initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $21.00

    10/21/24 8:25:47 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 4 filed by Salentine Thomas J Jr

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    3/31/26 4:05:05 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 4 filed by Ackerman John

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    3/31/26 4:05:05 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 4 filed by Cardinal Equity Fund, L.P.

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    3/31/26 4:05:08 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Cosler Steven D bought $99,786 worth of shares (3,370 units at $29.61), increasing direct ownership by 16% to 24,984 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    12/5/25 4:10:03 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Cosler Steven D bought $148,540 worth of shares (7,000 units at $21.22), increasing direct ownership by 65% to 17,713 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    11/20/24 4:05:12 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Salentine Thomas J Jr bought $499,996 worth of shares (35,714 units at $14.00) (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    10/1/24 5:48:50 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    12/6/24 12:05:09 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/14/24 4:30:13 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/14/24 1:01:24 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Financials

    Live finance-specific insights

    View All

    Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the fourth quarter and full year ended December 31, 2025. The Company also raised its full-year 2026 Adjusted EBITDA guidance. Fourth Quarter Financial Results Revenue of $397.6 million, up 17% year-over-year with organic growth of 12%. Residents served ended the quarter at approximately 205,000, up 10% year-over-year. Net Income of $21.3 million, up 81% from $11.8 million in the prior-year period. Adjusted EBITDA of $39.5 million, up 53% year over year. Diluted EPS of $0.33 for the quarter, with Adjusted

    3/11/26 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call

    Guardian Pharmacy Services, Inc. (NYSE:GRDN) today announced that it will release fourth quarter and full-year 2025 financial results after market close on Wednesday, March 11, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "93533." A replay will be available shortly after the call's completion and will remain available for approximately 60 days. About Guardian

    2/9/26 4:30:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss) of $9.6 million, compared to ($105.8) million in the prior-year period. Such year-over-year comparison is not meaningful due to income tax expense1 in the recently completed quarter, and certain one-time share-based

    11/10/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Leadership Updates

    Live Leadership Updates

    View All

    Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations

    Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif

    5/8/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy

    Guardian Pharmacy Services, (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian's Mid-Atlantic footprint and marks its first vent

    12/17/24 9:00:00 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples